Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis

The clinical pharmacology of elagolix was extensively evaluated in clinical studies in healthy subjects and in women with endometriosis. Elagolix pharmacokinetics (PK) show significant population variability, however they are minimally affected by patients’ baseline characteristics and demographics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shebley, Mohamad, Polepally, Akshanth R., Nader, Ahmed, Ng, Juki W., Winzenborg, Insa, Klein, Cheri E., Noertersheuser, Peter, Gibbs, Megan A., Mostafa, Nael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051932/
https://www.ncbi.nlm.nih.gov/pubmed/31749075
http://dx.doi.org/10.1007/s40262-019-00840-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051932/
https://www.ncbi.nlm.nih.gov/pubmed/31749075
http://dx.doi.org/10.1007/s40262-019-00840-7

Ejemplares similares